GENEVA, Nov. 10 -- CZAP RESEARCH AND DEVELOPMENT, LLC (1370 Trancas Street #350Napa, California 94558) filed a patent application (PCT/IB2025/054636) for "BLOOD GLUCOSE CONTROL WITH ENZYMATIC CYCLODEXTRIN INCLUSION COMPLEX FORMULATIONS" on May 02, 2025. With publication no. WO/2025/229618, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CZAP, Al (1370 Trancas Street #350Napa, California 94558)

Abstract: The invention provides oral cyclodextrin inclusion complex formulations in which inclusion complexes of oleuropein, hum...